Impact of the Novel Coronavirus Disease on Business Activities and Plan Disclosures
First written in FY2020. 7 of 11 entries say "Restated". Latest entry: FY2024-Q3.
The whole theme swung hardest in 2020: 102 of 175 companies on the "Worse" side.
- FY2024-Q3RestatedAnnual report
「During the nine-month period ended 31 December, Japan’s economy showed signs of normalization in economic activity, including the reclassification of COVID-19 under the Infectious Diseases Control Law as a Category V infectious disease. However, it remained in uncertain conditions owing to factors including higher raw material and crude oil prices, continued yen depreciation in foreign exchange markets, and heightened geopolitical risks.」
The company stated that economic activity was returning to normal, including through the reclassification of COVID-19 as a Category 5 infectious disease, while uncertainty in the external environment continued. - FY2024-Q2RestatedAnnual report
「During the first six months of the current consolidated fiscal year, Japan’s economy continued to operate in an uncertain environment despite signs of normalization in economic activity, including the reclassification of COVID-19 as a Category 5 infectious disease under the Infectious Diseases Control Law. The environment was affected by rising raw material and crude oil prices, a sharp depreciation of the yen in foreign exchange markets, and the prolonged situation in Ukraine.」
The company reconfirmed that economic activity was returning to normal following the reclassification of COVID-19 as a Category 5 infectious disease, while uncertainty in the external environment continued. - FY2024-Q1MitigatedAnnual report
「During the three-month period ended 30 June, Japan’s economy showed signs of normalization in economic activity, including the reclassification of COVID-19 under the Infectious Diseases Control Law as a Category V infectious disease. However, it remained in uncertain conditions owing to factors including higher raw material and crude oil prices, a rapid depreciation of the yen in foreign exchange markets, and the prolonged situation in Ukraine.」
The company stated that the classification of COVID-19 under the Infectious Diseases Control Law had been changed to Category 5 and that economic activity was returning to normal, indicating that the impact of the disease on business activities had eased in some respects. However, it stated that uncertainty about the outlook remained. - FY2023-Q1RestatedAnnual report
「During the three-month period ended 30 June, Japan’s economy remained in uncertain conditions owing to factors including continued effects from the COVID-19 pandemic, higher raw material and crude oil prices, a rapid depreciation of the yen in foreign exchange markets, and the prolonged situation in Ukraine.」
The company reconfirmed that the impact of COVID-19 was continuing and that conditions remained uncertain. - FY2022-Q3RestatedAnnual report
「During the first nine months of the current consolidated fiscal year, Japan’s economy showed signs of recovery as activity restrictions were gradually eased with the spread of vaccinations, but the outlook remained uncertain and challenging conditions were expected to continue because the economy was still affected by COVID-19.」
While referring to the easing of activity restrictions, the company reconfirmed its view that the impact of the infectious disease was continuing and that uncertain and challenging conditions would persist. - FY2022-Q2RestatedAnnual report
「However, the prolonged COVID-19 pandemic has left the outlook uncertain, and we expect challenging conditions to continue.」
While referring to a partial recovery due to vaccination and other factors, the company reconfirmed its view that the prolonged COVID-19 pandemic would leave an uncertain and challenging business environment in place. - FY2022-Q1RestatedAnnual report
「However, the prolonged COVID-19 pandemic has left the outlook uncertain, and we expect challenging conditions to continue.」
While there have been signs of a partial recovery due to vaccination and other factors, the company reconfirmed its view that the prolonged COVID-19 pandemic would leave a challenging and uncertain environment in place. - FY2021-Q3WorsenedAnnual report
「During the first nine months of the current consolidated fiscal year, Japan’s economy remained in a challenging condition because of the impact of COVID-19 in Japan and overseas. As the resurgence of infections became more serious in December, the economic outlook became extremely uncertain, and the situation remained difficult to predict.」
The company stated that the impact of COVID-19 was continuing, the resurgence of infections in December had become more serious, and the economic outlook had become extremely uncertain. - FY2021-Q2RestatedAnnual report
「Conditions remained challenging in Japan and overseas because of the impact of COVID-19, and the timing of the end of the pandemic could not be forecast, leaving the outlook uncertain and the situation difficult to predict.」
The company reconfirmed that the impact of COVID-19 was continuing and that a challenging business environment, with no clear prospect of when the pandemic would end, remained in place. - FY2021-Q1MaterialisedAnnual report
「As the timing of the containment of COVID-19 remains unclear, social and economic activity while implementing measures to prevent the spread of infection is expected to remain difficult.」
The company stated that the impact of COVID-19 was continuing and that there was no clear prospect of its containment. Production activities continued to be affected during the quarter by delays in procuring materials and components. - FY2020First statedAnnual report
「The global spread of COVID-19 and other novel infectious diseases could affect production activities, including by delaying component procurement for the group. Depending on how the situation develops, the group’s business activities could be restricted, potentially adversely affecting its business results and financial condition.」
COVID-19 was identified as a new business risk, and supply-chain impacts such as delays in component procurement had already occurred. In addition, disclosure of the new medium-term management plan was postponed because the outlook for the impact was difficult to assess.